skip to primary navigationskip to content
 

ilumink bought by technology specialist Tracerco

last modified Mar 06, 2015 01:37 PM
ilumink, which commercialises technology for brand authentication and anti-counterfeiting, has been acquired by industrial technology specialist Tracerco.

 

ilumink is based at ideaSpace West and is a spin-out company from the Department of Engineering at the University of Cambridge. Its approach is underpinned by novel, printed photonic materials created at the university.

Key applications include authentication, anti-counterfeiting and security products with potential markets ranging from high-value consumer goods through to pharmaceuticals. The technology is unique in offering brand owners overt, covert and forensic authentication in one easily applied print feature.

Damian Gardiner, founder of ilumink, said: “My colleagues and I are very much looking forward to becoming part of the Tracerco team. By combining our technical expertise and creativity, we can further develop our world-leading anti-counterfeiting and brand authentication technologies for our customers’ benefit.”

Tracerco is part of the Johnson Matthey Group. The acquisition will further enhance its product assurance portfolio, which is based on innovative and covert marker chemistry coupled with sophisticated analytical platforms.

Dr Vince Croud, Tracerco’s technology director, said: “The acquisition of ilumink will allow us to expand our portfolio of technology offerings to ensure we keep pace with the changing needs of customers. It is an excellent fit with the Tracerco business.”

For more information on the acquisition see the press release here.

RSS Feed Latest news

Sparrho Spreads its Wings

Jul 17, 2017

Sparrho raises $3 million to democratize access to science research

Silver Medal Awarded to Breath Biopsy Pioneer Billy Boyle

Jul 04, 2017

Owlstone Medical CEO Billy Boyle wins Royal Academy of Engineering’s Silver Medal

ideaSpace Alumni close three funding deals in a week

Jun 26, 2017

£4.3m raised in an exceptional 7 days for SyndicateRoom

Life sciences equity crowdfunding platform, Capital Cell shortlisted for international award

Jun 23, 2017

Shortlisted for the Best International Growth Business award at the UK Business Angels Association Investment Awards 2017

Addenbrooke's takes over the GeneAdviser ordering platform for genetic testing

Jun 21, 2017

GeneAdviser's platform to live on as in-house NHS tool

View all news